Inhibition of StAR expression, concomitant with E2 biosynthesis, by various HDACIs, in both human and mouse hormone-sensitive BC cells, underscores the therapeutic relevance of StAR selective for luminal subtype BCs. The gene discussed is STAR; the disease is breast cancer.